Lifeward Ltd. (LFWD)

Market Cap	18.76M
Revenue (ttm)	25.00M
Net Income (ttm)	-19.30M
Shares Out	10.63M
EPS (ttm)	-2.23
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	332,871
Open	1.850
Previous Close	1.840
Day's Range	1.750 - 1.880
52-Week Range	1.250 - 7.700
Beta	2.06
Analysts	Strong Buy
Price Target	9.17 (+419.55%)
Earnings Date	Mar 4, 2025

About LFWD

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological r...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 12, 2014
• Employees: 108
• Stock Exchange: NASDAQ
• Ticker Symbol: LFWD
• Website: https://golifeward.com

Financial Performance

In 2023, Lifeward's revenue was $13.85 million, an increase of 151.39% compared to the previous year's $5.51 million. Losses were -$22.13 million, 13.1% more than in 2022.

Analyst Forecast

According to 3 analysts, the average rating for LFWD stock is "Strong Buy." The 12-month stock price forecast is $9.17, which is an increase of 419.55% from the latest price.

Price Target

$9.17

(419.55% upside)

Analyst Consensus: Strong Buy